Andrew Murphy
Co-Chief Scientific Officer at Regeneron Pharmaceuticals. Based in Tarrytown, New York.
- Rank
- 2650th of 14,644
- Companies held
- 1
- Largest holding
- REGN, 100.0% of total
- Latest SEC filing
- Nov 17, 2026
What the $47.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Regeneron Pharmaceuticals REGN Common Stock | Directly | 46,779 | $927.12 | $43.4M | 91.4% | Form 4, Nov 17, 2026 |
| Regeneron Pharmaceuticals REGN Common Stock | Through 401(k) Plan | 4,414 | $927.12 | $4.1M | 8.6% | Form 4, Nov 16, 2026 |
Share counts are the amounts Andrew Murphy reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Sold | REGN | 93 | $949.69 | $88K | View |
| Nov 17, 2026 | Sold | REGN | 74 | $950.61 | $70K | View |
| Nov 17, 2026 | Sold | REGN | 298 | $951.75 | $284K | View |
| Nov 17, 2026 | Sold | REGN | 220 | $952.75 | $210K | View |
| Nov 17, 2026 | Sold | REGN | 671 | $953.69 | $640K | View |
| Nov 17, 2026 | Sold | REGN | 313 | $954.45 | $299K | View |
| Nov 17, 2026 | Sold | REGN | 313 | $955.48 | $299K | View |
| Nov 17, 2026 | Sold | REGN | 346 | $956.70 | $331K | View |
| Nov 17, 2026 | Sold | REGN | 202 | $957.53 | $193K | View |
| Nov 17, 2026 | Sold | REGN | 244 | $958.27 | $234K | View |
| Nov 17, 2026 | Sold | REGN | 506 | $959.45 | $485K | View |
| Nov 17, 2026 | Sold | REGN | 257 | $960.65 | $247K | View |
| Nov 17, 2026 | Sold | REGN | 584 | $961.45 | $561K | View |
| Nov 17, 2026 | Sold | REGN | 295 | $962.70 | $284K | View |
| Nov 17, 2026 | Sold | REGN | 255 | $963.60 | $246K | View |
| Nov 17, 2026 | Sold | REGN | 340 | $964.36 | $328K | View |
| Oct 14, 2026 | Sold | REGN | 6 | $753.76 | $5K | View |
| Oct 14, 2026 | Sold | REGN | 35 | $755.91 | $26K | View |
| Oct 14, 2026 | Sold | REGN | 16 | $757.68 | $12K | View |
| Oct 14, 2026 | Sold | REGN | 24 | $758.16 | $18K | View |
| Oct 14, 2026 | Sold | REGN | 14 | $759.96 | $11K | View |
| Oct 14, 2026 | Sold | REGN | 74 | $760.65 | $56K | View |
| Oct 14, 2026 | Sold | REGN | 27 | $761.36 | $21K | View |
| Oct 14, 2026 | Sold | REGN | 55 | $762.57 | $42K | View |
| Oct 14, 2026 | Sold | REGN | 25 | $763.76 | $19K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 2647 | Greg L. Armstrong Director, Plains GP Holdings. Houston, TX | $47.6M |
| 2648 | Michael Kirton Director, AerSale. Los Angeles, CA | $47.5M |
| 2649 | Julie P. Whalen EVP CHIEF FINANCIAL OFFICER, Williams-Sonoma. Saint Paul, MN | $47.5M |
| 2650 | Andrew Murphy Co-Chief Scientific Officer, Regeneron Pharmaceuticals. Tarrytown, NY | $47.5M |
| 2651 | Micheal G. Dunn Executive Vice President & COO, The Williams Companies. Tulsa, OK | $47.4M |
| 2652 | John T. Chambers Director, Bloom Energy. San Jose, CA | $47.3M |
| 2653 | Anre D. Williams Group Pres., Enterprise Serv., American Express. Palo Alto, CA | $47.3M |
Other Regeneron Pharmaceuticals insiders
All REGN insiders- Leonard S. Schleifer$2.22BBd. Co-Chair, President & CEO. #141 overall
- George Yancopoulos$858MBd. Co-Chair, President & CSO. #313 overall
- P. Roy Vagelos$433MDirector. #528 overall
- Neil E. Stahl$55.0MEVP Research and Development. #2375 overall
- Joseph LaRosa$44.6MEVP General Counsel and Secret. #2765 overall
- Daniel P. Van Plew$32.6MEVP & General Mgr, Industrial. #3540 overall
Questions
How much stock does Andrew Murphy own?
Andrew Murphy holds $47,462,157 in listed stock based on SEC filings and current prices, mostly Regeneron Pharmaceuticals (REGN). That ranks 2650th on the Stock Rich List.
Is this Andrew Murphy's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Andrew Murphy last buy or sell stock?
The most recent open-market trade on file is a sale of 93 REGN shares on Nov 17, 2026 at $949.69.